This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Amgen Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Alona Teran: Innovator in Pharmaceutical Formulations
Introduction
Alona Teran is a notable inventor based in Moorpark, CA (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative therapeutic solutions. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of protein-based medications.
Latest Patents
Alona's latest patents include "Reduced viscosity protein pharmaceutical formulations," which describes therapeutic protein formulations comprising N-methyl pyrrolidone (NMP). This invention outlines methods related to reducing the viscosity of pharmaceutical formulations and stabilizing them using NMP. Another significant patent is "Stable compositions of pegylated carfilzomib compounds," which provides stable pharmaceutical compositions of pegylated carfilzomib compounds. This patent details methods for preparing these compositions and their uses in treating cancer, including hematologic malignancies such as multiple myeloma. The compositions can be stored in frozen form or lyophilized to a dry solid form.
Career Highlights
Alona Teran is currently associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. Her work at Amgen has allowed her to contribute to groundbreaking advancements in the pharmaceutical industry.
Collaborations
Alona has collaborated with notable colleagues, including William Callahan and Qahera Munaim, who have also contributed to the field of pharmaceutical research.
Conclusion
Alona Teran's innovative work in pharmaceutical formulations demonstrates her commitment to improving therapeutic options for patients. Her patents reflect her expertise and dedication to advancing medical science.